Logo image of MYD

BLACKROCK MUNIYIELD FUND (MYD) Stock Overview

NYSE:MYD - US09253W1045

9.99 USD
+0.03 (+0.3%)
Last: 8/28/2025, 8:04:00 PM
Fundamental Rating

2

Overall MYD gets a fundamental rating of 2 out of 10. We evaluated MYD against 0 industry peers in the Unkown industry. MYD has a bad profitability rating. Also its financial health evaluation is rather negative. MYD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MYD was profitable.
MYD had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MYD reported negative net income in multiple years.
Of the past 5 years MYD 4 years had a positive operating cash flow.
MYD Yearly Net Income VS EBIT VS OCF VS FCFMYD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Industry RankSector Rank
ROA 2.64%
ROE 3.03%
ROIC 1.89%
ROA(3y)-2.41%
ROA(5y)0.24%
ROE(3y)-2.92%
ROE(5y)0.18%
ROIC(3y)2.13%
ROIC(5y)2.22%
MYD Yearly ROA, ROE, ROICMYD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

In the last couple of years the Profit Margin of MYD has declined.
In the last couple of years the Operating Margin of MYD has declined.
MYD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 55.07%
PM (TTM) 62.53%
GM 56.2%
OM growth 3Y-10.72%
OM growth 5Y-4.47%
PM growth 3Y-39.76%
PM growth 5Y-6.24%
GM growth 3Y-10.63%
GM growth 5Y-4.36%
MYD Yearly Profit, Operating, Gross MarginsMYD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, MYD has less shares outstanding
The number of shares outstanding for MYD has been reduced compared to 5 years ago.
Compared to 1 year ago, MYD has a worse debt to assets ratio.
MYD Yearly Shares OutstandingMYD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MYD Yearly Total Debt VS Total AssetsMYD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.36 indicates that MYD is not a great score, but indicates only limited risk for bankruptcy at the moment.
MYD has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 2.36
ROIC/WACCN/A
WACCN/A
MYD Yearly LT Debt VS Equity VS FCFMYD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.60 indicates that MYD may have some problems paying its short term obligations.
A Quick Ratio of 0.60 indicates that MYD may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.6
MYD Yearly Current Assets VS Current LiabilitesMYD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

MYD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 533.33%, which is quite impressive.
The earnings per share for MYD have been decreasing by -10.59% on average. This is quite bad
Looking at the last year, MYD shows a small growth in Revenue. The Revenue has grown by 3.72% in the last year.
The Revenue has been decreasing by -4.99% on average over the past years.
EPS 1Y (TTM)533.33%
EPS 3Y-41.14%
EPS 5Y-10.59%
EPS Q2Q%-102.94%
Revenue 1Y (TTM)3.72%
Revenue growth 3Y-2.91%
Revenue growth 5Y-4.99%
Sales Q2Q%5.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MYD Yearly Revenue VS EstimatesMYD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MYD is valuated rather expensively with a Price/Earnings ratio of 19.21.
Compared to an average S&P500 Price/Earnings ratio of 27.17, MYD is valued a bit cheaper.
Industry RankSector Rank
PE 19.21
Fwd PE N/A
MYD Price Earnings VS Forward Price EarningsMYD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYD Per share dataMYD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.52%, MYD is a good candidate for dividend investing.
MYD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 6.52%

5.2 History

The dividend of MYD decreases each year by -6.67%.
MYD has paid a dividend for at least 10 years, which is a reliable track record.
MYD has decreased its dividend recently.
Dividend Growth(5Y)-6.67%
Div Incr Years1
Div Non Decr Years1
MYD Yearly Dividends per shareMYD Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

122.89% of the earnings are spent on dividend by MYD. This is not a sustainable payout ratio.
MYD's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP122.89%
EPS Next 2YN/A
EPS Next 3YN/A
MYD Yearly Income VS Free CF VS DividendMYD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
MYD Dividend Payout.MYD Dividend Payout, showing the Payout Ratio.MYD Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKROCK MUNIYIELD FUND

NYSE:MYD (8/28/2025, 8:04:00 PM)

9.99

+0.03 (+0.3%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)04-01 2025-04-01
Earnings (Next)10-01 2025-10-01
Inst Owners30.69%
Inst Owner Change3.38%
Ins OwnersN/A
Ins Owner Change0%
Market Cap456.84M
Analysts0
Price TargetN/A
Short Float %0.11%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 6.52%
Yearly Dividend0.51
Dividend Growth(5Y)-6.67%
DP122.89%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-15 2025-08-15 (0.0545)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 19.21
Fwd PE N/A
P/S 11.94
P/FCF N/A
P/OCF N/A
P/B 0.58
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)0.52
EY5.21%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS0.84
BVpS17.3
TBVpS17.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.64%
ROE 3.03%
ROCE 2.39%
ROIC 1.89%
ROICexc 1.89%
ROICexgc 1.89%
OM 55.07%
PM (TTM) 62.53%
GM 56.2%
FCFM N/A
ROA(3y)-2.41%
ROA(5y)0.24%
ROE(3y)-2.92%
ROE(5y)0.18%
ROIC(3y)2.13%
ROIC(5y)2.22%
ROICexc(3y)2.13%
ROICexc(5y)2.22%
ROICexgc(3y)2.13%
ROICexgc(5y)2.22%
ROCE(3y)2.7%
ROCE(5y)2.81%
ROICexcg growth 3Y-5.47%
ROICexcg growth 5Y-5.11%
ROICexc growth 3Y-5.48%
ROICexc growth 5Y-5.12%
OM growth 3Y-10.72%
OM growth 5Y-4.47%
PM growth 3Y-39.76%
PM growth 5Y-6.24%
GM growth 3Y-10.63%
GM growth 5Y-4.36%
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.72
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.6
Altman-Z 2.36
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)533.33%
EPS 3Y-41.14%
EPS 5Y-10.59%
EPS Q2Q%-102.94%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.72%
Revenue growth 3Y-2.91%
Revenue growth 5Y-4.99%
Sales Q2Q%5.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.24%
EBIT growth 3Y-13.32%
EBIT growth 5Y-9.23%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-104.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-124.81%
OCF growth 3YN/A
OCF growth 5YN/A